A. Scapellato

Azienda Ospedaliera San Giovanni Addolorata

Papers

3

Total Citations

45

H-Index

2

About

A. Scapellato is a urological surgeon and researcher whose work focuses on refining surgical outcomes and prognostic accuracy in prostate cancer management. His key research areas include optimizing post-operative recovery protocols and improving risk stratification for patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Scapellato’s major contribution lies in demonstrating that prostate-specific antigen (PSA) density is a reliable predictor of both upstaging and upgrading of prostate cancer under the contemporary grading system, offering clinicians a simple, readily available tool to guide treatment decisions. This work, published in 2017, has garnered 34 citations, underscoring its practical impact. He has also pioneered efforts to shorten post-operative catheterization, showing that removing the urinary catheter on post-operative day 2 after RALP is feasible and safe in a high-volume referral center—a finding that challenges traditional protocols and may reduce patient discomfort and recovery time. With additional studies reinforcing this approach, Scapellato’s research contributes to a growing body of evidence aimed at making prostate cancer surgery less invasive and more patient-centered.

Research Focus

Key Achievements

2
H-Index
3
Papers
45
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Prostate-specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System: The Keys We Are Seeking May Be Already in Our Pocket
34 citations · 2017
📈 Most Prolific Year: 2017 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Azienda Ospedaliera San Giovanni Addolorata

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago